Mechanism of matrix metalloproteinase axis-induced neointimal growth

Journal of Molecular and Cellular Cardiology

Volumn 66, Issue , 2014, Pages 116-125

  Guo, Ling ^a   Ning, Wenhu ^a   Tan, Zhen ^a   Gong, Zhaowei ^a   Li, Xueqi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Femoral artery wire injury; MMPs; Neointimal hyperplasia; PDGF; TNF

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMORAL ARTERY; GENE EXPRESSION; IN VITRO STUDY; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL;

MUS;

FEMORAL ARTERY WIRE INJURY; MMPS; NEOINTIMAL HYPERPLASIA; PDGF; TNF-Α;

ANIMALS; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; GENE EXPRESSION; HYPERPLASIA; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA;

EID: 84889986220     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.11.014     Document Type: Article

References (41)

1. Kushner E.J., Bautch V.L. Building blood vessels in development and disease. Curr Opin Hematol 2013, 20:231-236.
2. Mayr M., Xu Q. Smooth muscle cell apoptosis in arteriosclerosis. Exp Gerontol 2001, 36:969-987.
3. Dzau V.J., Braun-Dullaeus R.C., Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 2002, 8:1249-1256.
4. Newby A.C., Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. J Pathol 2000, 190:300-309.
5. Stone J.D., Narine A., Shaver P.R., Fox J.C., Vuncannon J.R., Tulis D.A. AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury. Am J Physiol Heart Circ Physiol 2013, 304:H369-H381.
6. Korshunov V.A., Berk B.C. Smooth muscle apoptosis and vascular remodeling. Curr Opin Hematol 2008, 15:250-254.
7. Sata M., Maejima Y., Adachi F., Fukino K., Saiura A., Sugiura S., et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 2000, 32:2097-2104.
8. Zalewski A., Shi Y., Johnson A.G. Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyondα. Circ Res 2002, 91:652-655.
9. Rectenwald J.E., Moldawer L.L., Huber T.S., Seeger J.M., Ozaki C.K. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 2000, 102:1697-1702.
10. Ray D., Nelson T.A., Fu C.L., Patel S., Gong D.N., Odegaard J.I., et al. Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise. PLoS Negl Trop Dis 2012, 6:e1912.
11. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
12. Hellstrom M., Kalen M., Lindahl P., Abramsson A., Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055.
13. Balasubramaniam V., Le Cras T.D., Ivy D.D., Grover T.R., Kinsella J.P., Abman S.H. Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 2003, 284:L826-L833.
14. Lijnen H.R. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001, 86:324-333.
15. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002, 90:251-262.
16. Chen Q., Jin M., Yang F., Zhu J., Xiao Q., Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm 2013, 2013:928315.
17. Johnson C., Galis Z.S. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol 2004, 24:54-60.
18. Auge N., Maupas-Schwalm F., Elbaz M., Thiers J.C., Waysbort A., Itohara S., et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 2004, 110:571-578.
19. Pruijt J.F., Fibbe W.E., Laterveer L., Pieters R.A., Lindley I.J., Paemen L., et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Natl Acad Sci U S A 1999, 96:10863-10868.
20. Xue H., Sun K., Xie W., Hu G., Kong H., Wang Q., et al. Etanercept attenuates short-term cigarette-smoke-exposure-induced pulmonary arterial remodelling in rats by suppressing the activation of TNF-a/NF-kB signal and the activities of MMP-2 and MMP-9. Pulm Pharmacol Ther 2012, 25:208-215.
21. Wagsater D., Zhu C., Bjorck H.M., Eriksson P. Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression. Atherosclerosis 2009, 202:415-423.
22. Zhang Y., Dong J., He P., Li W., Zhang Q., Li N., et al. Genistein inhibit cytokines or growth factor-induced proliferation and transformation phenotype in fibroblast-like synoviocytes of rheumatoid arthritis. Inflammation 2012, 35:377-387.
23. Risinger G.M., Updike D.L., Bullen E.C., Tomasek J.J., Howard E.W. TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB. Am J Physiol Cell Physiol 2010, 298:C191-C201.
24. Henrichot E., Juge-Aubry C.E., Pernin A., Pache J.C., Velebit V., Dayer J.M., et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosisα. Arterioscler Thromb Vasc Biol 2005, 25:2594-2599.
25. Shimizu I., Walsh K. Vascular remodeling mediated by Angptl2 produced from perivascular adipose tissue. J Mol Cell Cardiol 2013, 59C:176-178.
26. Szasz T., Bomfim G.F., Webb R.C. The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag 2013, 9:105-116.
27. Takaoka M., Nagata D., Kihara S., Shimomura I., Kimura Y., Tabata Y., et al. Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ Res 2009, 105:906-911.
28. Inoue T., Mori M., Shimono R., Kuwano H., Sugimachi K. Vascular invasion of colorectal carcinoma readily visible with certain stains. Dis Colon Rectum 1992, 35:34-39.
29. Gu Z., Cui J., Brown S., Fridman R., Mobashery S., Strongin A.Y., et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 2005, 25:6401-6408.
30. Moon S.K., Cha B.Y., Kim C.H. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway. J Cell Physiol 2004, 198:417-427.
31. Bendeck M.P., Irvin C., Reidy M.A. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 1996, 78:38-43.
32. Peppel K., Zhang L., Orman E.S., Hagen P.O., Amalfitano A., Brian L., et al. Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms. Cardiovasc Res 2005, 65:674-682.
33. Timar J., Dome B., Fazekas K., Janovics A., Paku S. Angiogenesis-dependent diseases and angiogenesis therapy. Pathol Oncol Res 2001, 7:85-94.
34. Papaharalambus C.A., Griendling K.K. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 2007, 17:48-54.
35. Newby A.C. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 2006, 69:614-624.
36. Cho A., Graves J., Reidy M.A. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000, 20:2527-2532.
37. Li H., Liang J., Castrillon D.H., DePinho R.A., Olson E.N., Liu Z.P. FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription. Mol Cell Biol 2007, 27:2676-2686.
38. Okuno T., Andoh A., Bamba S., Araki Y., Fujiyama Y., Fujiyama M., et al. Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol 2002, 37:317-324.
39. Okada Y., Tsuchiya H., Shimizu H., Tomita K., Nakanishi I., Sato H., et al. Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun 1990, 171:610-617.
40. Newby A.C. Metalloproteinases and vulnerable atherosclerotic plaques. Trends Cardiovasc Med 2007, 17:253-258.
41. Galis Z.S., Johnson C., Godin D., Magid R., Shipley J.M., Senior R.M., et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002, 91:852-859.